FIELD: medicine, organic chemistry, pharmacy. SUBSTANCE: invention relates to development of novel medicinal preparations inhibiting proliferation of lymphocytes. Invention proposes the novel biologically active compound 2-amino-6-(1-ethyl-2-methyl-4- nitroimidazolyl-5)-thiopurine inhibiting proliferation of lymphocytes. 2-Amino-6-(1-ethyl-2-methyl-4- nitriomidazolyl-5)-thiopurine inhibits the primary immune response of animals for thymus-depending and thymus- nondepending antigens effectively. These preparations can be used in practical medicine for carrying out immunodepressive and antileukosis therapy. EFFECT: new compound indicated above, enhanced effectiveness, expanded therapeutic action. 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF IMMUNOSUPPRESSION | 2008 |
|
RU2393481C1 |
| METHOD OF EXTRACTING IMMUNODEPRESSOR FROM TISSUE OF MAMMALIA | 0 |
|
SU1243730A1 |
| METHOD OF DETERMINING ACTIVITY OF IMMUNODEPRESSOR OF BIOGENIC NATURE | 0 |
|
SU1350615A1 |
| METHOD FOR PREVENTING SECONDARY ALVEOLAR ECHINOCOCCOSIS (HYDATIDOSIS) | 2004 |
|
RU2279274C2 |
| LINEAR OR CYCLIC PEPTIDES, THEIR USING AND METHOD OF PATIENT TREATMENT | 1993 |
|
RU2130317C1 |
| REGENERATING RESOLVENT AND WAYS OF TREATMENT BY MEANS OF THIS AGENT | 2007 |
|
RU2362554C2 |
| SYNERGIC COMBINATION OF PROTEASOME INHIBITOR AND VITAMIN K FOR INHIBITION OF GROWTH AND PROLIFERATION OF TUMOUR CELLS, PHARMACEUTICAL COMPOSITION AND THEREOF-BASED ANTI-TUMOUR MEDICATION | 2013 |
|
RU2563986C2 |
| DIPEPTIDYL PEPTIDASE IV INHIBITING AGENT AND PHARMACEUTICAL COMPOSITION THEREOF | 2011 |
|
RU2485952C2 |
| MEDICAL PRODUCT AND METHOD OF RHEUMATIC DISEASES TREATMENT | 2006 |
|
RU2330664C2 |
| PEPTIDE FROM THE COMPOSITION OF THE IMMUNOGLOBULIN HUMAN HEAVY CHAIN, SUITABLE FOR TREATMENT OF MULTIPLE SCLEROSIS | 2016 |
|
RU2646817C1 |
